Keyang Xu

Keyang Xu is a Senior Fellow at Genentech, where they are responsible for developing novel bioanalytical strategies using hybrid ligand binding and mass spectrometry techniques. From 2017 to 2024, Keyang served as a Distinguished Scientist, focusing on the characterization and quantification of protein therapeutics. They previously held positions as a Principal Scientist and Scientist at Genentech, as well as a Senior Scientist at Amgen, and a Postdoc at the University of Pennsylvania. Keyang is currently pursuing a Ph.D. in Chemistry at the University of Pittsburgh and holds a B.Sc. in Chemistry from Xiamen University.